Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
19,204,130
-
Shares change
-
+3,354,795
-
Total reported value, excl. options
-
$331,600,145
-
Value change
-
+$58,337,064
-
Number of buys
-
56
-
Number of sells
-
23
-
Price
-
$17.27
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q1 2017
As of 31 Mar 2017 CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) had 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,204,130 shares of stock of the company.
Largest 10 holders included FMR LLC, BVF INC/IL, PERCEPTIVE ADVISORS LLC, BlackRock Inc., DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, EcoR1 Capital, LLC, Redmile Group, LLC, Tekla Capital Management LLC, and Opaleye Management Inc..
This table shows 91 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.